Junshi Biosciences Announces Toripalimab’s Approval in Australia

Published on January 17, 2025 by Banzai

SHANGHAI, Jan. 17, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therap…

Read Original Article Back to Articles